研究実績

A phase II study of perioperative capecitabine plus oxaliplatin (CapeOx) therapy for advanced gastric cancer with multiple lymph node metastases (OGSG 1701)

Shunji Endo, Yutaka Kimura, Naotoshi Sugimoto, Ryohei Kawabata, Atsushi Takeno,                Jin Matsuyama, Motohiro Imano, Daisuke Sakai, Hisato Kawakami, Shigeyuki Tamura,        Masato Nakamura, Hiroki Takeshita, Shogen Boku, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh

ASCO-GI 2024, San Francisco California United States 18  – 20 Jan 2024

前の記事 次の記事 一覧ページへ戻る